MEDICATION AND REGULATION OF ACUTE POSTOPERATORY PAIN, USING MULTIMODAL THERAPY

Authors

  • G. V. TĂNASE Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania
  • Adina Elena TĂNASE Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania
  • C. G. ILEA Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania
  • Manuela CIOCOIU Grigore T. Popa University of Medicine and Pharmacy Iasi, Romania

DOI:

https://doi.org/10.22551/

Abstract

Surgical interventions and opioid exposure activate both peripheral (satellite glial cells) and central glia (microglia and astrocytes), contributing to peripheral and central sensitization and maintenance of pain. Specific molecules such as MMP-9 and IL-1β are involved. Materials and methods: We analyzed female patients who presented for emergency or elective abdominal surgery at the “Cuza-Voda” Hospital of Obstetrics and Gynecology Iași, Romania and who met the following inclusion criteria and did not present any of the exclusion criteria were included in the analysis. Inclusion criteria: Age over 18 years; Surgical obstetrical or gynecological indication. exclusion criteria: patients under 18 years of age; people with suspected sepsis or serious medical comorbidities such as heart failure, undiagnosed fever and instable state. The study was retrospective and prospective, during January 2024 to November 2025, starting from the clinical parameters, surgery indication, analyzing clinically and paraclinically, the importance of intra- and post-operative analgesic medication that was used. Results: Of the total study group, 52.3% of patients underwent cesarean sections (CST), 14.4% underwent total hysterectomy with bilateral adnexectomy (HT+AB) and 9% underwent biopsy curettage, the rest of gynecological surgeries consisted of Madden mastectomy, salpingectomy, ovarian cyst removal. Multimodal drug therapy and opioid treatments were required to achieve the control of post operatory pain. Conclusions: Current areas of interest in pain research include investigating the effect of mood on pain processing in the brain and the search for new drugs to block the channels involved in pain transmission, and the actual important post operatory pain therapy involves a combination of multimodal and opioid treatments.

References

1. Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 2014; 13(7): 533-548.

2. Matsuda M, Huh Y, Ji RR. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J Anesth 2019; 33(1): 131-139.

3. Tanaka M, Török N, Tóth F, et al. Co-Players in Chronic Pain: Neuroinflammation and the Trypto-phan-Kynurenine Metabolic Pathway. Biomedicines 2021; 9(8): 897.

4. Gianò M, Franco C, Castrezzati S, et al. Involvement of Oxidative Stress and Nutrition in the Anatomy of Orofacial Pain. International Journal of Molecular Sciences 2023; 24(17): 13128.

5. Solleiro-Villavicencio H, Rivas-Arancibia S. Effect of Chronic Oxidative Stress on Neuroinflammatory Response Mediated by CD4+T Cells in Neurodegenerative Diseases. Front Cell Neurosci 2018; 12: 114.

6. Afridi B, Khan H, Akkol EK, et al. Pain Perception and Management: Where do We Stand? Curr Mol Pharmacol 2021; 14(5): 678-688.

7. Crofford LJ. Chronic Pain: Where the Body Meets the Brain. Trans Am Clin Climatol Assoc 2015; 126: 167-183.

8. Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160(1): 19-27.

9. Schrepf A, Gallop R, Naliboff B, et al. Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network. Clinical Phenotyping for Pain Mechanisms in Urologic Chronic Pelvic Pain Syndromes: A MAPP Research Network Study. J Pain 2022; 23(9): 1594-1603.

10. Nijs J, Lahousse A, Kapreli E, et al. Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future. J Clin Med 2021; 10(15): 3203.

11. Nijs J, Meeus M, Cagnie B, et al. A modern neuroscience approach to chronic spinal pain: combining pain neuroscience education with cognition-targeted motor control training. Phys Ther 2014; 94(5): 730-738.

12. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965; 150(3699): 971-979.

13. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011; 31(5): 986-1000.

14. Li H, Xie W, Strong JA, et al. Systemic anti-inflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuro-pathic pain. Anesthesiology 2007; 107(3): 469-477.

15. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acet-aminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002; 99(21): 13926-13931.

16. Ninković J, Roy S. Role of the mu-opioid receptor in opioid modulation of immune function. Amino Acids 2013; 45(1): 9-24.

17. Schmidt P, Ruchelli G, Mackey SC, et al. Perioperative gabapentinoids: choice of agent, dose, timing, and effects on chronic postsurgical pain. Anesthesiology 2013; 119: 1215-1221.

18. Premkumar LS, Sikand P. TRPV1: a target for next generation anal- gesics. Curr Neuropharmacol 2008; 6(2): 151-163.

19. BJ Anderson, GA Woollard, NH Holford. Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy. Eur J Clin Pharmacol 2001; 57(8): 559-569.

20. Brown JK, Singh K, Dumitru R, et al. The benefits of enhanced recovery after surgery programs and their application in cardiothoracic surgery. Methodist Debakey Cardiovasc J 2018; 14(2): 77-88.

21. Kong J, Schnyer R, Johnson K, et al. Complementary and alternative medicine for cancer pain: an overview of systematic reviews. Evid Based Complement Alternat Med 2013; 2013: 187-182.

Additional Files

Published

2026-04-01

Issue

Section

INTERNAL MEDICINE - PEDIATRICS